000 01577 a2200457 4500
005 20250513213155.0
264 0 _c20000706
008 200007s 0 0 eng d
022 _a0012-1797
024 7 _a10.2337/diabetes.49.2.218
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBraghi, S
245 0 0 _aModulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes.
_h[electronic resource]
260 _bDiabetes
_cFeb 2000
300 _a218-24 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntibody Formation
650 0 4 _aAutoantibodies
_xanalysis
650 0 4 _aAutoantigens
_xanalysis
650 0 4 _aAutoimmunity
_ximmunology
650 0 4 _aDiabetes Mellitus, Type 1
_ximmunology
650 0 4 _aEpitopes
_ximmunology
650 0 4 _aGlutamate Decarboxylase
_ximmunology
650 0 4 _aGraft Survival
_ximmunology
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aPancreas Transplantation
_ximmunology
650 0 4 _aPostoperative Period
650 0 4 _aProtein Tyrosine Phosphatase, Non-Receptor Type 1
650 0 4 _aProtein Tyrosine Phosphatases
_ximmunology
650 0 4 _aTransplantation, Homologous
650 0 4 _aTreatment Outcome
700 1 _aBonifacio, E
700 1 _aSecchi, A
700 1 _aDi Carlo, V
700 1 _aPozza, G
700 1 _aBosi, E
773 0 _tDiabetes
_gvol. 49
_gno. 2
_gp. 218-24
856 4 0 _uhttps://doi.org/10.2337/diabetes.49.2.218
_zAvailable from publisher's website
999 _c10819736
_d10819736